The observation that ATM is a modulator of FLIP protein levels whose aberrant upregulation has been linked to apoptosis deregulation and to cancer therapy resistance in many tumors [66], provides a novel link between ATM loss of function and the acquired resistance of cancer cells to apoptosis. The gene discussed is ATM; the disease is cancer.